Malignant bowel obstruction;Maligne intestinale obstruktion

Zeitschrift fur Gastroenterologie

Volumn 48, Issue 2, 2010, Pages 264-273

  Zom, M ^a   Domagk, D ^b   Auerbauch, T ^c   Mais, J ^a   Brauckhoff, T ^a   Holtmann, M H ^a  

^a St Vincenz Krankenhaus   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Radiotogische KIinik   (Germany)

Author keywords

Colorectal cancer; Malassimilation; Malignant bowel obstruction; Oesophageal carcinoma; Palliative medicine; Stomach cancer

Indexed keywords

DEXAMETHASONE; DIMENHYDRINATE; DOLASETRON MESILATE; GRANISETRON; HALOPERIDOL; LEVOMEPROMAZINE; LORAZEPAM; METOCLOPRAMIDE; OCTREOTIDE; ONDANSETRON; PROMETHAZINE; SCOPOLAMINE; SCOPOLAMINE BUTYL BROMIDE; TROPISETRON;

ABDOMINAL RADIOGRAPHY; CANCER PALLIATIVE THERAPY; HUMAN; ILEUS; INTESTINE CANCER; INTESTINE ENDOSCOPY; INTESTINE OBSTRUCTION; PATHOPHYSIOLOGY; REVIEW;

AGED; COLOSTOMY; ENTERAL NUTRITION; ESOPHAGEAL STENOSIS; FEMALE; GASTRIC OUTLET OBSTRUCTION; GASTROINTESTINAL NEOPLASMS; HUMANS; INTESTINAL OBSTRUCTION; MALE; PALLIATIVE CARE; PATIENT CARE TEAM; PERITONEAL NEOPLASMS; STENTS;

EID: 77749341106     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1109774     Document Type: Review

References (101)

1. Holtmann MH, Domagk D, Weber M et al. Gastroenterological palliative care. Z Gastroenterol 2007; 46 (7): 712-724
2. Krouse RS. Surgical management of malignant bowel obstruction. Surg Oncol Clin N Am 2004; 13 (3): 479-490
3. Ripamonti C, Bruera E. Palliative management of malignant bowel obstruction. Int J Gynecol Cancer 2002; 12(2): 135-143
4. Anthony T, Baron T, Mercadante S et al. Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction. J Pain Symptom Manage 2007; 34 (1 Suppl): S49-S59
5. Aabo K, Pedersen H, Bach F et al. Surgical management of intestinal obstruction in the late course of malignant disease. Acta Chir Scand 1984; 150(2): 173-176
6. Averbach AM, Sugarbaker PH. Recurrent intraabdominal cancer with intestinal obstruction. Int Surg 1995; 80 (2): 141-146
7. Baines M. The pathophysiology and management of malignant bowel obstruction In: Doyle D, Hanks G, MacDonald N (Hrsg). Oxford textbook of palliative medicine. Oxford: Oxford University Press, 1998: 526-534
8. Ripamonti CI, Easson AM, Gerdes H. Management of malignant bowel obstruction. Eur J Cancer 2008; 44 (8): 1105-1115
9. Krebs HB, Goplerud DR. Surgical management of bowel obstruction in advanced ovarian carcinoma. Obstet Gynecol 1983; 61 (3): 327-330
10. Kaasa S, Hjermstad MJ, Loge JH. Methodological and structural challenges in palliative care research: how have we fared in the last decades? Palliat Med 2006; 20 (8): 727-734
11. Easson AM, Lee KF, Brasel K et al. Clinical research for surgeons in palliative care: challenges and opportunities. J Am Coll Surg 2003; 196 (1): 141-151
12. Spiegel D. Effects of psychotherapy on cancer survival. Nat Rev Cancer 2002; 2 (5): 383-389
13. Delabrousse E, Destrumelle N, Brunelle S et al. CT of small bowel ob-struction in adults. Abdom Imaging 2003; 28 (2): 257-266
14. DiSantis DJ, Ralls PW, Balfe DM et al. The patient with suspected small bowel obstruction: imaging strategies. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215 (Suppl): 121-124
15. Furukawa A, Yamasaki M, Furuichi K et al. Helical CT in the diagnosis of small bowel obstruction. Radiographics 2001; 21 (2): 341-355
16. Chung CC, Meng WC, Yu SC et al. A prospective study on the use of water-soluble contrast follow-through radiology in the management of small bowel obstruction. Aust N Z J Surg 1996; 66 (9): 598-601
17. Ericksen AS, Krasna MJ, Mast BA et al. Use of gastrointestinal contrast studies in obstruction of the srnall and large bowel. Dis Colon Rectum 1990: 33(1): 56-64
18. Tang E, Davis J, Silberman H. Bowel obstruction in cancer patients. Arch Surg 1995; 130 (8): 832-836, discussion 836-837
19. Legendre H, Vanhuyse F, Caroli-Bosc FX et al. Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction. Eur J Surg Oncol 2001; 27 (4): 364-367
20. Makela J, Kiviniemi H, Laitinen S et al. Surgical management of intestinal obstruction after treatment for cancer. Case reports. Eur J Surg 1991; 157(1): 73-77
21. Feuer DJ, Broadley KE, Shepherd JH et al. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev 2000; 4: CD002764
22. Yazdi GP, Miedema BW, Humphrey LJ. High mortality after abdominal operation in patients with large-volume malignant ascites. J Surg Oncol 1996; 62 (2): 93-96
23. Blair SL, Chu DZ, Schwarz RE. Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. Ann Surg Oncol 2001; 8 (8): 632-637
24. Higashi H, Shida H, Ban K et al. Factors affecting successful palliative surgery for malignant bowel obstruction due to peritoneal dissemination from colorectal cancer. Jpn J Clin Oncol 2003; 33 (7): 357-359
25. Isla AM, Worthington T, Kakkar AK et al. A continuing role for surgical bypass in the palliative treatment of pancreatic carcinoma. Dig Surg 2000; 17 (2): 143-146
26. Choi YB. Laparoscopic gatrojejunostomy for palliation of gastric outlet obstruction in unresectable gastric cancer. Surg Endosc 2002; 16 (11): 1620-1626
27. Ripamonti C, Twycross R, Baines M et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 2001; 9 (4): 223-233
28. van Ooijen B, van der Burg ME, Planting AS et al. Surgical treatment or gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin. Surg Gynecol Obstet 1993; 176 (5): 469-474
29. Kozarek RA. Endoscopic palliation of esophageal malignancy. Endoscopy 2003; 35(8): S9-S13
30. Domschke W, Foerster EC, Matek W et al. Self-expanding mesh stent for esophageal cancer stenosis. Endoscopy 1990; 22 (3): 134-136
31. Baron TH. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 2001; 344 (22): 1681-1687
32. Baron TH, Harewood GC. Enteral self-expandable stents. Gastrointest Endosc 2003; 58 (3): 421-433
33. Lowe AS, Beckett CG, Jowett S et al. Self-expandable metal stent placement for the palliation of malignant gastroduodenal obstruction: experience in a large, single, UK centre. Clin Radiol 2007; 62 (8): 738-744
34. Telford JJ, Carr-Locke DL, Baron TH et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest Endosc 2004; 60 (6): 916-920
35. Nassif T, Prat F, Meduri B et al. Endoscopic palliation of malignant gastric outlet obstruction using self-expandable metallic stents: results of a multicenter study. Endoscopy 2003; 35 (6): 483-489
36. Law WL, Choi HK, Lee YM et al. Palliation for advanced malignant colorectal obstruction by self-expanding metallic stents: prospective evaluation of outcomes. Dis Colon Rectum 2004; 47 (1): 39-43
37. Camunez F, Echenagusia A, Simo G et al. Malignant colorectal obstruction treated by means of self-expanding metallic stents: effectiveness before surgery and in palliation. Radiology 2000; 216 (2): 492-497
38. Sibille A, Lambert R, Souquet JC et al. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995; 108 (2): 337-344
39. Ban H, Kendall C, Stone N. Photodynamic therapy for esophageal cancer: a useful and realistic option. Technol Cancer Res Treat 2003; 2 (1): 65-76
40. Knyrim K, Wagner HJ, Bethge N et al. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993; 329 (18): 1302-1307
41. Neuhaus H, Hoffmann W, Dittler HJ et al. Implantation of self-expanding esophageal metal stents for palliation of malignant dysphagia. Endoscopy 1992; 24(5): 405-410
42. Adam A, Ellul J, Watkinson AF et al. Palliation of inoperable esophageal carcinoma: a prospective randomized trial of laser therapy and stent placement. Radiology 1997; 202 (2): 344-348
43. Dallai HJ, Smith GD, Grieve DC et al. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc 2001; 54 (5): 549-557
44. Siersema PD, Hop WC, van Blankenstein M et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 2001; 54(2): 145-153
45. Morgan RA, Ellul JP, Denton ER et al. Malignant esophageal fistulas and perforations: management with plastic-covered metallic endoprostheses. Radiology 1997; 204 (2): 527-532
46. Dua KS, Kozarek R, Kim J et al. Self-expanding metal esophageal stent with anti-reflux mechanism. Gastrointest Endosc 2001; 53 (6): 603-613
47. Wenger U, Johnsson E, Arnelo U et al. An antireflux stent versus conventional stents for palliation of distal esophageal or cardia cancer: a randomized clinical study. Surg Endosc 2006; 20 (11): 1675-1680
48. Shim CS, Jung IS, Cheon YK et al. Management of malignant stricture of the esophagogastric junction with a newly designed self-expanding metal stent with an antireflux mechanism. Endoscopy 2005; 37 (4): 335-339
49. Kinsman KJ, DeGregorio BT, Katon RM et al. Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancy. Gastrointest Endosc 1996; 43 (3): 196-203
50. Dua KS. Stents for palliating malignant dysphagia and fistula: is the paradigm shifting? Gastrointest Endosc 2007; 65 (1): 77-81
51. Dormann A, Meisner S, Verin N et al. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy 2004; 36 (6): 543-550
52. Yim HB, Jacobson BC, Saltzman JR et al. Clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction. Gastrointest Endosc 2001; 53 (3): 329-332
53. Feretis C, Benakis P, Dimopoulos C et al. Palliation of malignant gastric outlet obstruction with self-expanding metal stents. Endoscopy 1996; 28 (2): 225-228
54. Graber I, Dumas R, Filoche B et al. The efficacy and safety of duodenal stenting: a prospective multicenter study. Endoscopy 2007; 39 (9): 784-787
55. Seo EH, Jung MK, Park MJ et al. Covered expandable nitinol stents for malignant gastroduodenal obstructions. J Gastroenterol Hepatol 2008; 23: 1056-1062
56. Espinel J, Sanz O, Vivas S et al. Malignant gastrointestinal obstruction: endoscopic stenting versus surgical palliation. Surg Endosc 2006; 20 (7): 1083-1087
57. Jeurnink SM, Steyerberg EW, Hof G et al. Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. J Surg Oncol 2007; 96 (5): 389-396
58. Wong YT, Brams DM, Munson L et al. Gastric outlet obstruction secondary to pancreatic cancer: surgical vs. endoscopic palliation. Surg Endosc 2002; 16(2): 310-312
59. Schiefke I, Zabel-Langhennig A, Wiedmann M et al. Self-expandable metallic stents for malignant duodenal obstruction caused by biliary tract cancer. Gastrointest Endosc 2003; 58 (2): 213-219
60. Mutignani M, Tringali A, Shah SG et al. Combined endoscopic stent insertion in malignant biliary and duodenal obstruction. Endoscopy 2007; 39 (5): 440-447
61. Maire F, Hammel P, Ponsot P et al. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas. Am J Gastroenterol 2006; 101 (4): 735-742
62. Mehta S, Hindmarsh A, Cheong E et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc 2006; 20 (2): 239-242
63. Rabeneck L, McCullough LB, Wray NP. Ethically justified, clinically comprehensive guidelines for percutaneous endoscopic gastrostomy tube placement. Lancet 1997; 349 (9050): 496-498
64. Synofzik M. Tube-feeding in advanced dementia. An evidence-based ethical analysis. Nervenarzt 2007; 78 (4): 418-428
65. Campagnutta E, Cannizzaro R, Gallo A et al. Palliative treatment of upper intestinal obstruction by gynecological malignancy: the usefulness of percutaneous endoscopic gastrostomy. Gynecol Oncol 1996; 62 (1): 103-105
66. Pothuri B, Montemarano M, Gerardi M et al. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Gynecol Oncol 2005; 96 (2): 330-334
67. Law WL, Choi HK, Chu KW. Comparison of stenting with emergency surgery as palliative treatment for obstructing primary left-sided colorectal cancer. Br J Surg 2003; 90 (11): 1429-1433
68. Fregonese D, Naspetti R, Ferrer S et al. Ultraflex precision colonic stent placement as a bridge to surgery in patients with malignant colon obstruction. Gastrointest Endosc 2008; 67 (1): 68-73
69. Baron TH, Rey JF, Spinelli P. Expandable metal stent placement for malignant colorectal obstruction. Endoscopy 2002; 34 (10): 823-830
70. Baron TH. Acute colonic obstruction. Gastrointest Endosc Clin N Am 2007; 17 (2): 323-339, vi
71. Caceres A, Zhou Q, Iasonos A et al. Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series. Gynecol Oncol 2008; 108 (3): 482-485
72. Knot UP, Lang AW, Murali K et al. Systematic review of the efficacy and safety of colorectal stents. Br J Surg 2002; 89 (9): 1096-1102
73. Repiri A, Fregonese D, Costamagna G et al. Ultraflex precision colonic stent placement for palliation of malignant colonic obstruction: a prospective multicenter study. Gastrointest Endosc 2007; 66 (5): 920-927
74. Karoui M, Charachon A, Delbaldo C et al. Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration. Arch Surg 2007; 142 (7): 619-623, discussion 623
75. Ramadori G, Lindhorst A, Armbrust T. Colorectal tumors with complete obstruction - endoscopic recovery of passage replacing emergency surgery? A report of two cases. BMC Gastroenterol 2007; 7:14
76. Baumhoer D, Armbrust T, Ramadori G. Nonsurgical treatment of the primary tumor in four consecutive cases of metastasized colorectal carcinoma. Endoscopy 2005; 37 (12): 1232-1236
77. Armbrust T, Sobotta M, Füzesi L et al. Chemotherapie-induced suppression to adenoma or complete suppression of the primary in patients with stage IV colorectal cancer: report of four cases. European Journal of Gastroenterology & Hepatology 2007; 19 (11): 988-994
78. Kaasa S, De Conno F. Palliative care research. Eur J Cancer 2001; 37 (Suppl 8): S153-S159
79. Baines M, Oliver DJ, Carter RL. Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study. Lancet 1985; 2 (8462): 990-993
80. Holtmann MH, Siepmann U, Mahlkow S et al. Gastroenterologische Symptomkontrolle in der Palliativmedizin (Teil 1). Der Gastroenterologe 2008; 4 (1): 64-73
81. Holtmann MH, Siepmann U, Mahlkow S et al. Gastroenterologische Symptomkontrolle in der Palliativmedizin (Teil 2). Der Gastroenterologe 2009; 4 (2): 147-156
82. Relief WHOCP. Geneva, 1996; 2nd ed
83. Mercadante S, Porzio G, Ferrera P et al. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain 2008; 12 (8): 1040-1046
84. Hanks GW, Conno F, Cherny N et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 2001; 84 (5): 587-593
85. Meissner W, Schmidt U, Hartmann M et al. Oral naloxone reverses opioid-associated constipation. Pain 2000; 84 (1): 105-109
86. Thomas J, Karver S, Cooney GA et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008; 358 (22): 2332-2343
87. Glare P, Pereira G, Kristjanson LJ et al. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer 2004; 12 (6): 432-440
88. Critchley P, Plach N, Grantham M et al. Efficacy of haloperidol in the treatment of nausea and vomiting in the palliative patient: a systematic review. J Pain Symptom Manage 2001; 22 (2): 631-634
89. Feuer DJ, Broadley KE. Systematic review and meta-analysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Systematic Review Steering Committee. Ann Oncol 1999; 10 (9): 1035-1041
90. Philip J, Lickiss N, Grant PT et al. Corticosteroids in the management of bowel obstruction on a gynecological oncology unit. Gynecol Oncol 1999; 74 (1): 68-73
91. Ripamonti C, Panzeri C, Groff L et al. The role of somatostatin and octreotide in bowel obstruction: pre-clinical and clinical results. Tumori 2001; 87 (1): 1-9
92. Anthone GJ, Bastidas JA, Orandle MS et al. Direct proabsorptive effect of octreotide on ionic transport in the small intestine. Surgery 1990; 108 (6): 1136-1141, discussion 1141-1142
93. Dean A. The palliative effects of octreotide in cancer patients. Chemotherapy 2001; 47 (Suppl 2): 54-61
94. Bastounis E, Hadjinikolaou L, Ioannou N et al. Somatostatin as adjuvant therapy in the management of obstructive ileus. Hepatogastroenterology 1989; 36 (6): 538-539
95. Ripamonti C, Mercadante S, Groff L et al. Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage 2000; 19 (1): 23-34
96. Mangili G, Franchi M, Mariani A et al. Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynecol Oncol 1996; 61 (3): 345-348
97. Mercadante S, Spoldi E, Caraceni A et al. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 1993; 7 (4): 295-299
98. Mercadante S, Ripamonti C, Casuccio A et al. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer 2000; 8 (3): 188-191
99. Cozzaglio L, Balzola F, Cosentino F et al. Outcome of cancer patients receiving home parenteral nutrition. Italian Society of Parenteral and Enteral Nutrition (S. I. N. P.E.). JPEN J Parenter Enteral Nutr 1997; 21 (6): 339-342
100. Burge FI. Dehydration symptoms of palliative care cancer patients. J Pain Symptom Manage 1993; 8 (7): 454-464
101. Hoda D, Jatoi A, Burnes, J et al. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience. Cancer 2005; 103 (4): 863-868